City

Busan (1)

Cairo (1)

Condition

Macular Ischemia (2)

Alzheimer Disease (1)

Amyloid Angiopathy (1)

Dementia (1)

Diabetic Macular Edema (1)

Diabetic Retinopathy (1)

Mild Cognitive Impairment (1)

Vascular Endothelial Growth Factor Overexpression (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Cairo University (1)

Pusan National University Hospital (1)

Collaborator

Intervention

intravitreal bevacizumab (1)

intravitreal ranibizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

macular ischemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

OCTA Factors in or Without Amyloid Pathology: A Prospective

Completed

Alzheimer Disease
+4 more

Busan, Korea, Republic of

Pusan National University Hospital

Jul 24, 2022

Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal

Recruiting

Diabetic Macular Edema
+3 more

Intravitreal ranibizumab
Intravitreal bevacizumab

Cairo, Egypt

Cairo University

Nov 26, 2021